Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis

Journal of Surgical Research

Volumn 61, Issue 2, 1996, Pages 348-354

  Dunne, James R ^a   Dunkin, Brian J ^b   Nelson, Steve ^c   White, Jon C ^d,e  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNE RESPONSE; LEUKOCYTE COUNT; MALE; NEUTROPHIL; NONHUMAN; PERITONEUM LAVAGE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

EID: 0029869877     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0128     Document Type: Article

References (37)

1. Parrillo, J. E., moderator. Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113: 227, 1990.
2. Tracey, K. J., and Cerami, A. Tumor necrosis factor: An updated review of its biology. Crit. Care Med. 21(Supp): 415, 1993.
3. Lange, J. R., Alexander, H. R., Merino, M. J., Doherty, G. M., and Norton, J. A. Interleukin-1α prevention of the lethality of Escherichia coli peritonitis. J. Surg. Res. 52: 555, 1992.
4. Fisher, C. J., Opal, S. M., Dhainaut, J. F., Stephens, S., Zimmerman, J. L., Nightingale, P., et al. Influence of an antitumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit. Care Med. 21: 318, 1993.
5. Fisher, C. J., Dhainaut, J. F., Opal, S. M., Pribble, J. P., and the Phase III rIL-1ra Sepsis Syndrome Study Group. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized double-blind, placebo-controlled trial. JAMA 271: 1836, 1994.
6. Garcia, C., Saladino, R., Thompson, C., et al. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits. Crit. Care Med. 22: 1211, 1994.
7. Fisher, C. J., and Mara, M. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: A placebo-controlled study. Crit. Care Med. 22: 553, 1994.
8. Teng, N. N. H., Kaplan, H. S., Moore, C., et al. Protection against gram-negative bacteremia and endotoxin with human monoclonal IgM antibodies. Proc. Natl. Acad. Sci. U.S.A. 82: 1790, 1985.
9. Zeigler, E. J., Teng, N. H. H., Douglas, H., Wunderlich, A., Berger, H. J., and Bolmer, S. D. Treatment of Pseudomonas bacteremia in neutropenic rabbits with human monoclonal IgM antibody against E. coli lipid A. Clin. Res. 35: 619A, 1987.
10. Bone, R. C., Balk, R. A., and Fein, A. M. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial. Crit. Care Med. 23: 994, 1995.
11. Brun-Buisson, C., Lepoutre, A., Blot, F., et al. The French national registry of HA-1A (Centoxin) in septic shock: A cohort study of 600 patients. Arch. Intern. Med. 154: 2484, 1994.
12. Ziegler, E. J., Fisher, C. J., Sprung, C. L., and the HA-1A Sepsis Study Group. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N. Engl. J. Med. 324: 29, 1991.
13. Babineau, T. J., Marcello, P., et al. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann. Surg. 20: 601, 1994.
14. Zsebo, K. M., Yuschenkoff, V. N., Schiffer, et al. Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 71: 99, 1988.
15. Lieschke, G. J., and Burgess, A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 327: 28, 1992.
16. Sieff, C. A. Hematopoietic growth factors. J. Clin. Invest. 19: 1549, 1987.
17. Nelson, S., Summers, W., Bagby, G., et al. Granulocyte colony stimulating factor enhances pulmonary host defenses in normal and ethanol treated rats. J. Infect. Dis. 164: 901, 1991.
18. Mooney, D. P., Gamelli, R. L., O'Reilly, M., and Herbert, J. C. Recombinant human granulocyte colony stimulating factor and Pseudomonas burn wound sepsis. Arch. Surg. 123: 1253, 1988.
19. Cairo, M. S., Mauss, D., Kommareddy, S., et al. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B Streptococcal sepsis in neonatal rats. Pediatr. Res. 27: 612, 1990.
20. Gragrilove, J. L., Jakubowski, A., Scher, H., et al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N. Engl. J. Med. 318: 114, 1988.
21. Hammond, W. P., Price, T. H., Souza, L. M., et al. Treatment of cyclic neutropenia with granulocyte colony stimulating factor. N. Engl. J. Med. 320: 1306, 1989.
22. Sheridan, W. P., Morstyn, G., Wolf, M., et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2: 89, 1989.
23. Cairo, M. S. Review of G-CSF and GM-CSF effects on neonatal neutrophil kinetics. Am. J. Pediatri. Hematol. Oncol. 11(2): 238, 1989.
24. Boyum, A. Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 2(Suppl 97): 77, 1986.
25. Nelson, S. Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: An overview. Clin. Infect. Dis. 18(Suppl 2): S197, 1994.
26. Athens, J. W., Roab, S. O., Haab, O. P., et al. Leukokinetic studies III. The distribution of granulocytes in the blood of normal subjects. J. Clin. Invest. 40: 159, 1961.
27. White, J. C., Nelson, S., Winkelstein, A., et al. Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection. J. Infect. Dis. 153: 202, 1986.
28. O'Reilly, M., Silver, G., Greenhalgh, D. G., Gamelli, R. L., et al. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J. Trauma. 33: 679, 1992.
29. Yasuda, H., Ajiki, Y., et al. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect. Immun. 58: 2502, 1990.
30. Fink, M. P., O'Sullivan, B. P., Menconi, M. J., et al. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J. Trauma 34: 571, 1993.
31. Wang, J. M., Ahen, G. C., Colella, S., et al. Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 72: 1456, 1988.
32. Cohen, A. M., Hines, D. K., Korach, E. S., and Ratzkin, B. J. In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor. Infect. Immun. 56: 2861, 1988.
33. Weiland, J. E., Davis, W. B., Holter, J. F., et al. Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiologic significance. Am. Rev. Respir. Dis. 133: 218, 1986.
34. Lange, C. H., Bagby, G. J., Dobrescu, C., Nelson, S., and Spitzer, J. J. Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J. Infect. Dis. 166: 336, 1992.
35. Simms, H. H., and D'Amico, R. Granulocyte colony-stimulating factor reverses septic shock-induced polymorphonuclear leukocyte dysfunction. Surgery 115: 85, 1994.
36. Goya, T., Torisu, M., Doi, F., and Yoshida, T. Effects of granulocyte colony stimulating factor and monobactam antibiotics (Aztreonam) on neutrophil functions in sepsis. Clin. Immunol. Immunopathol. 69: 278, 1993.
37. Roilides, E., Walsh, T. J., Pizzo, P. A., and Rubin, M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163: 579, 1991.